Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Patient”

708 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 708 results

Testing effectiveness (Phase 2)Study completedNCT03917407
What this trial is testing

DUR-928 in Patients With Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
Craig James McClain 43
Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Not applicableStudy completedNCT05546450
What this trial is testing

Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease Patients

Who this might be right for
Fatty Liver DiseaseObesityLiver Fat
Istanbul Gelisim University 108
Testing effectiveness (Phase 2)Looking for participantsNCT06863376
What this trial is testing

Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Tanta University 46
Testing effectiveness (Phase 2)Study completedNCT03863574
What this trial is testing

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Zydus Therapeutics Inc. 16
Post-approval studies (Phase 4)UnknownNCT05942963
What this trial is testing

Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2diabetes
Jinnah Postgraduate Medical Centre 240
Not applicableEnded earlyNCT02345421
What this trial is testing

Identify and Characterize LAL-D Patients in High-risk Populations

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 640
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Post-approval studies (Phase 4)Study completedNCT05459701
What this trial is testing

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Rehab Werida 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07632222
What this trial is testing

High-Protein Diet for Improving Alcoholic Fatty Liver Disease

Who this might be right for
Alcohol-associated Fatty Liver Disease
Li Lab,MD 74
Not applicableLooking for participantsNCT05477212
What this trial is testing

Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.

Who this might be right for
Permeability; IncreasedNAFLDObesity
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 30
Not applicableStudy completedNCT02048267
What this trial is testing

Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis

Who this might be right for
Pancreatitis, Chronic
Post Graduate Institute of Medical Education and Research, Chandigarh 24
Not applicableStudy completedNCT04180631
What this trial is testing

Quantitative US for Hepatic Steatosis

Who this might be right for
Hepatic Steatosis
Seoul National University Hospital 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Large-scale testing (Phase 3)Study completedNCT05768334
What this trial is testing

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Helwan University 116
Not applicableStudy completedNCT01820819
What this trial is testing

Is Access to Liver Transplantation Similar in Alcoholic or Not Patients?

Who this might be right for
Inpatient With End Stage Liver Disease
Assistance Publique - Hôpitaux de Paris 574
Not applicableStudy completedNCT05092399
What this trial is testing

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLDObesity
University of Nottingham 21
Not applicableLooking for participantsNCT06814600
What this trial is testing

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Who this might be right for
NAFLDInflammatory Bowel DiseasesSteatosis+1 more
Centre Hospitalier Universitaire Saint Pierre 150
Testing effectiveness (Phase 2)Study completedNCT00501592
What this trial is testing

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Who this might be right for
Diabetes Mellitus, Type IIFatty Liver
Intercept Pharmaceuticals 64
Not applicableUnknownNCT05359471
What this trial is testing

Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD

Who this might be right for
Visceral SteatosisHivNAFLD
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Next Page